VIVS Stock Analysis: Buy, Sell, or Hold?
VIVS - VivoSim Labs, Inc. Common Stock
$1.11
-0.02 (-1.77%)
▼
5d:
-5.13%
30d:
-18.38%
90d:
-31.48%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jun 25, 2026
TODAY
Get Alerted When VIVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VIVS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VIVS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VIVS is currently trading at $1.11, which is considered oversold relative to its 30-day fair value range of $1.15 to $1.31.
Technical Outlook: Technically, VIVS is in a strong downtrend. The price is currently testing key support at $1.13. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VIVS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VIVS is in a strong downtrend. The price is currently testing key support at $1.13. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: VIVS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.15 -
$1.31
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- CAUTION: 5-day price weakness (-5.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.15 -
$1.31
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.13
Resistance Level
$1.35
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Revenue Growth (YoY)
8.3%
Share & Embed Analysis
Last updated: June 24, 2026 11:43 AM ET
Data refreshes hourly during market hours. Next update: 12:43 PM
Data refreshes hourly during market hours. Next update: 12:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VIVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
